The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Diversity of Mechanism-Based Pharmacodynamic Models
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Emergent Properties of Networks of Biological Signaling Pathways
Bhalla, U. S., & Iyengar, R. (1999) · Science · doi:10.1126/science.283.5400.381 · Cited by 1,686
Simultaneous modeling of pharmacokinetics and pharmacodynamics: Application to d‐tubocurarine
Sheiner, L. B., Stanski, D. R., Vozeh, S., Miller, R. D., & Ham, J. (1979) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1979253358 · Cited by 1,134
Operational models of pharmacological agonism
Black, J. W., & Leff, P. (1983) · Proceedings of the Royal Society of London. Series B. Biological Sciences · doi:10.1098/rspb.1983.0093 · Cited by 951
Pharmacologic Analysis of Drug Receptor Interaction
Kenakin, K. T. (1988) · Therapeutic Drug Monitoring · doi:10.1097/00007691-198803000-00029 · Cited by 927
Comparison of four basic models of indirect pharmacodynamic responses
Dayneka, N. L., Garg, V., & Jusko, W. J. (1993) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01061691 · Cited by 821
Self-citationPharmacokinetic/pharmacodynamic data analysis : concepts and applications
Gabrielsson, J., & Weiner, D. (2002) · Cited by 704
General Pharmacokinetic Model for Drugs Exhibiting Target-Mediated Drug Disposition
Mager, D. E., & Jusko, W. J. (2001) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1023/a:1014414520282 · Cited by 605
Self-citationKinetics of pharmacologic response
Holford, N. H. G., & Sheiner, L. B. (1982) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(82)90051-1 · Cited by 501
The Pharmacology of Vascular Smooth Muscle
(1996) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780192623874.001.0001 · Cited by 439
Physiologic indirect response models characterize diverse types of pharmacodynamic effects
Jusko, W. J., & Ko, H. C. (1994) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1994.155 · Cited by 360
Self-citationPharmacologic target-mediated drug disposition
Levy, G. (1994) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1994.134 · Cited by 332
Wagner, J. G. (1968) · Journal of Theoretical Biology · doi:10.1016/0022-5193(68)90188-4 · Cited by 305
THE PHARMACOLOGY OF VASCULAR SMOOTH MUSCLE
FURCHGOTT, R. F. (1955) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06984-4 · Cited by 284
Kinetics of pharmacologic effects in man: The anticoagulant action of warfarin
Nagashima, R., O'Reilly, R. A., & Levy, G. (1969) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt196910122 · Cited by 230
Affinity and intrinsic activity in the theory of competitive inhibition. I. Problems and theory.
Ej, A. (1954) · PubMed · Cited by 218
Kinetics of pharmacologic effects
Levy, G. (1966) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt196673362 · Cited by 196
Peck, C. C., Barr, W. H., Benet, L. Z., Collins, J., Desjardins, R. E., Furst, D. E., Harter, J. G., Levy, G., Ludden, T., Rodman, J. H., et al. (1992) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1992.47 · Cited by 191
Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics
Lew, K. H., Ludwig, E. A., Milad, M. A., Donovan, K., Jr., E. M., Ferry, J. J., & Jusko, W. J. (1993) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1993.167 · Cited by 169
Self-citationSun, Y.-N., & Jusko, W. J. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js970414z · Cited by 162
Self-citationJusko, W. J. (1971) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600600618 · Cited by 160
Self-citationPharmacodynamic modeling of time-dependent transduction systems
Mager, D. E., & Jusko, W. J. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.118244 · Cited by 145
Self-citationMouton, J. W., Vinks, A. A. T. M. M., & Punt, N. C. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.4.733 · Cited by 142
Sharma, A., Ebling, W. F., & Jusko, W. J. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js980171q · Cited by 132
Self-citationLobo, E. D., & Balthasar, J. P. (2002) · AAPS PharmSci · doi:10.1208/ps040442 · Cited by 130
Textbook of Receptor Pharmacology
Foreman, J. C., Johansen, T., & Gibb, A. J. (2010) · CRC Press eBooks · doi:10.1201/9781420052558 · Cited by 127
Prednisolone Pharmacokinetics and Pharmacodynamics in Relation to Sex and Race
Magee, M. H., Blum, R. A., Lates, C. D., & Jusko, W. J. (2001) · The Journal of Clinical Pharmacology · doi:10.1177/00912700122012733 · Cited by 125
Self-citationCharacterization of four basic models of indirect pharmacodynamic responses
Sharma, A., & Jusko, W. J. (1996) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf02353483 · Cited by 124
Self-citationRamakrishnan, R., DuBois, D. C., Almon, R. R., Pyszczynski, N. A., & Jusko, W. J. (2002) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1023/a:1015765201129 · Cited by 116
Self-citationMechanism-based pharmacodynamic modeling
Levy, G. (1994) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1994.149 · Cited by 87
Application of Logistic Growth Model to Pharmacodynamic Analysis of in Vitro Bactericidal Kinetics
Yano, Y., Oguma, T., Nagata, H., & Sasaki, S. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js9801337 · Cited by 86
Visser, S. A. G., Wolters, F. L. C., Gubbens-Stibbe, J. M., Tukker, E., van der Graaf, P. H., Peletier, L. A., & Danhof, M. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.042341 · Cited by 85
Basic Pharmacodynamic Models for Agents That Alter Production of Natural Cells
Krzyżański, W., Ramakrishnan, R., & Jusko, W. J. (1999) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1023/a:1023249813106 · Cited by 85
Self-citationChakraborty, A., Krzyżański, W., & Jusko, W. J. (1999) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1023/a:1020678628317 · Cited by 84
Self-citationZhi, J., Nightingale, C. H., & Quintiliani, R. (1988) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01062551 · Cited by 80
Gisleskog, P. O., Hermann, D. J., Hammarlund‐Udenaes, M., & Karlsson, M. O. (1998) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(98)90054-6 · Cited by 68
Receptor-Mediated Pharmacokinetic/Pharmacodynamic Model of Interferon-β 1a in Humans
Mager, D. E., & Jusko, W. J. (2002) · Pharmaceutical Research · doi:10.1023/a:1020468902694 · Cited by 63
Self-citationConvergence of direct and indirect pharmacodynamic response models
Jusko, W. J., Ko, H. C., & Ebling, W. F. (1995) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf02353781 · Cited by 60
Self-citationPeck, C. C., Barr, W. H., Benet, L. Z., Collins, J. M., Desjardins, R. E., Furst, D. E., Harter, J. G., Levy, G., Ludden, T. M., Rodman, J. H., et al. (1994) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1994.tb03974.x · Cited by 52
Zuideveld, K. P., Maas, H. J., Treijtel, N., Hulshof, J., van der Graaf, P. H., Peletier, L. A., & Danhof, M. (2001) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2001.281.6.r2059 · Cited by 50
Benincosa, L. J., Chow, F. S., Tobia, L. P., et al. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35355-8 · Cited by 44
Krzyzanski, W., & Jusko, W. (1998) · Journal of pharmacokinetics and biopharmaceutics · doi:10.1023/a:1021060000789 · Cited by 33
Self-citationHoffman, A., & Goldberg, A. (1994) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf02353789 · Cited by 26
Perlstein, I., Stepensky, D., Krzyżański, W., et al. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10243 · Cited by 24
Krzyżański, W., & Jusko, W. J. (2001) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1023/a:1011517718990 · Cited by 22
Self-citationKatashima, M., Yamamoto, K., Tokuma, Y., Hata, T., Sawada, Y., & Iga, T. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37328-8 · Cited by 8
Cited by
Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids.
Czock, D., Keller, F., Rasche, F. M., & H??ussler, U. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544010-00003 · Cited by 886
The Hill equation: a review of its capabilities in pharmacological modelling
Goutelle, S., Maurin, M., Rougier, F., Barbaut, X., Bourguignon, L., Ducher, M., & Maire, P. (2008) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2008.00633.x · Cited by 867
In silico toxicology: computational methods for the prediction of chemical toxicity
Raies, A. B., & Bajic, V. B. (2016) · WIREs Computational Molecular Science · doi:10.1002/wcms.1240 · Cited by 744
A microfluidic device for a pharmacokinetic–pharmacodynamic (PK–PD) model on a chip
Sung, J. H., Kam, C., & Shuler, M. L. (2010) · Lab on a Chip · doi:10.1039/b917763a · Cited by 484
Zou, H. Y., Friboulet, L., Kodack, D. P., Engstrom, L. D., Li, Q., West, M., Tang, R. W., Wang, H., Tsaparikos, K., Wang, J., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.05.010 · Cited by 471
Metadata
- Authors
- Mager, D. E., Wyska, E., & Jusko, W. J.
- Venue
- Drug Metabolism and Disposition
- Publisher
- Elsevier BV
- Published
- 2003-05
- Volume
- 31
- Issue
- 5
- Pages
- 510-518
- ISSN
- 0090-9556 (ISSN-L)
- OpenAlex
- W2107065429
- Cited by
- 345
- References
- 45
- FWCI
- 10.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.